<DOC>
	<DOCNO>NCT01793597</DOCNO>
	<brief_summary>Patients heart attack regularly treat either clopidogrel ticagrelor . In large clinical trial , treatment ticagrelor coronary bypass surgery ( CABG ) associate low risk death treatment clopidogrel . The reason difference explain basis study . One possible explanation reversible bind ticagrelor advantageous new platelet release , inhibited drug . Because clopidogrel bind irreversibly redistribute . The investigator recruit patient schedule surgery acute coronary syndrome treat either ticagrelor clopidogrel . After patient provide informed consent , investigator review medical record , record information day surgery investigator take one sample blood . That blood analyze evidence platelet activation ( platelet microparticles , platelet-leukocyte aggregate ) , reactivity young platelet , concentration inflammatory cytokine . The investigator hypothesize evidence platelet activation ( platelet microparticles platelet-leukocyte aggregate ) reactivity young platelet le patient treat previously ticagrelor .</brief_summary>
	<brief_title>Platelet Reactivity After CABG</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Acute coronary syndrome , CABG , within 48 hour last dose clopidogrel ticagrelor , treatment aspirin Treatment antiplatelet agent aspirin , clopidogrel , ticagrelor , Acute chronic hematologic disorder include preoperative Hgb le 10 g/dl platelet count less 100,000/mm3 , Moderate severe renal insufficiency ( glomerular filtration rate le 60 ml/min ) , Active infection , Active malignancy , Unable/unwilling provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>ticagrelor</keyword>
	<keyword>Coronary artery bypass surgery</keyword>
	<keyword>platelet function</keyword>
	<keyword>receptor binding</keyword>
	<keyword>platelet reactivity</keyword>
	<keyword>reversible binding</keyword>
</DOC>